Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2030 participants
INTERVENTIONAL
2025-01-09
2025-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Programs to Promote Colon Cancer Screening
NCT01411826
Evaluating Online Messages About Colon Cancer Screening
NCT06134089
Colorectal Cancer Screening in Alaska Native Men
NCT06436300
Regional Native American Community Networks Program (RNACNP)
NCT02843217
Social Media for Colorectal Cancer Screening
NCT04296630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (no exposure)
Participants in the Control Arm will not be shown any messages.
Control
There will be no message content of cancer screening and sharing intentions in this arm.
Median Ranked
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
Overall Preferred
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
Black American Preferred
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
White American Preferred
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Median Ranked Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
Overall Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
Black American Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
White American Preferred Cancer Screening Messaging
Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
Control
There will be no message content of cancer screening and sharing intentions in this arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previously diagnosed with colorectal cancer
* Non-English speakers
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
AmeriSpeak - NORC
UNKNOWN
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andy King, PhD
Role: PRINCIPAL_INVESTIGATOR
Huntsman Cancer Institute/ University of Utah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Andy King
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCI183491
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.